Advertise
Ophthalmology Times® offers custom-designed programs to fit the needs of your brand. By utilizing our omnichannel marketing levers you will have access to our highly engaged audience and receive guaranteed, quality results.
Let's work together - Contact Us!
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
2
First patient treated in ViaLase’s IDE trial
3
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5



.png)


